Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alfred S Callahan

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
The Journal of the American Board of Family Practice|December 3, 2005
Long-term therapy to prevent strokeHoward S Kirshner, José Biller, Alfred S Callahan
Cerebrovascular Diseases (Basel, Switzerland)|October 31, 2003
Design and baseline characteristics of the stroke prevention by aggressive reduction in cholesterol levels (SPARCL) studyPeirre Amarenco, Julien Bogousslavsky, Alfred S Callahan, et al.
Cerebrovascular Diseases (Basel, Switzerland)|May 26, 2004
Statins for secondary stroke prevention in patients without known coronary heart disease: the jury is still outLarry B Goldstein, Pierre Amarenco, Julien Bogousslavsky, et al.
Stroke|April 5, 2003
Factors influencing outcome and treatment effect in PROACT IILawrence R Wechsler, Robin Roberts, Anthony J Furlan, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
The Journal of the American Board of Family Practice|December 3, 2005
Long-term therapy to prevent strokeHoward S Kirshner, José Biller, Alfred S Callahan
Cerebrovascular Diseases (Basel, Switzerland)|October 31, 2003
Design and baseline characteristics of the stroke prevention by aggressive reduction in cholesterol levels (SPARCL) studyPeirre Amarenco, Julien Bogousslavsky, Alfred S Callahan, et al.
Cerebrovascular Diseases (Basel, Switzerland)|May 26, 2004
Statins for secondary stroke prevention in patients without known coronary heart disease: the jury is still outLarry B Goldstein, Pierre Amarenco, Julien Bogousslavsky, et al.
Stroke|April 5, 2003
Factors influencing outcome and treatment effect in PROACT IILawrence R Wechsler, Robin Roberts, Anthony J Furlan, et al.
Pageof 1